Erythropoietin Drugs Market Size & Growth

 

As per the research conducted by GME, the Global Erythropoietin Drugs Market will grow with a CAGR value of 11.2 percent by 2026. There are various kinds of erythropoietin drugs accessible in the market among those Epogen is the main blockbuster biologic for anemia by Amgen sanctioned by the FDA and is broadly utilized. The rising rate of chronic kidney diseases and developing business sectors and colossal investment in research work are the variables liable for the development of this market.  

Browse 153 Market Data Tables and 113 Figures spread through 183 Pages and in-depth TOC on “Global Erythropoietin Drugs Market - Forecast to 2026” 

https://www.globalmarketestimates.com/market-report/global-erythropoietin-drugs-market-3221

By Application (Renal Diseases, Cancer, Neurology, Hematology), By Drugs Class (Biosimilars, Biologics), By Product (Darbepoetin-alfa, Epoetin-alfa, Epoetin-beta, Others), By Region (North America, Asia Pacific, CSA, Europe, and the Middle East and Africa); End-User Landscape, Company Market Share Analysis & Competitor Analysis

Key Market Insights

·       The hormone erythropoietin (EPO), also known as haemopoietin, is produced endogenously by the kidneys and plays an important role in the generation of red blood cells (RBCs).

·       Red platelets are formed in the bone marrow and aid in the transport of oxygen throughout the body. Epoetin alfa arose as the largest segment due to acquisitions among medical services experts.

·       The recent introduction of erythropoietin biosimilars in the United States is believed to indicate a change in global EPO medication development from biologics to biosimilars.

·       Because of the rising frequency of chronic diseases and the strong demand for low-cost therapies, the Asia Pacific EPO sector is expected to develop at the quickest CAGR.

·       Dr. Reddy’s Laboratories Ltd., Johnson & Johnson, Sun Pharmaceutical Industries Ltd, Celltrion, Inc., Intas Pharmaceuticals Ltd., Teva Pharmaceutical Industries Ltd., Biocon Limited, Amgen, Inc., LG Life Sciences Ltd., and F. Hoffmann-La Roche Ltd. are the top players in the Erythropoietin Drugs Market.

Browse the Report @ https://www.globalmarketestimates.com/market-report/global-erythropoietin-drugs-market-3221

Application Outlook (Revenue, USD Billion, 2021-2026)

·       Renal Diseases

·       Cancer

·       Neurology

·       Hematology

Drug Class Outlook (Revenue, USD Billion, 2021-2026)

·       Biosimilars

·       Biologics

Product Outlook (Revenue, USD Billion, 2021-2026)

·       Darbepoetin-alfa

·       Epoetin-alfa

·       Epoetin-beta

·       Others

Regional Outlook (Revenue, USD Billion, 2021-2026)

North America                                                                                 

• The U.S.
• Canada
• Mexico

Europe

• Germany
• UK
• France
• Spain
• Italy
• Rest of Europe

Asia Pacific

• China
• India
• Japan
• South Korea
• Australia
• Rest of APAC

Central & South America

• Brazil
• Argentina
• Rest of CSA

Middle East & Africa

• Saudi Arabia
• UAE
• Rest of MEA

 

 

Contact: Tracy Simon

Email address: tracy.simon@globalmarketestimates.com

Phone Number: +16026667238

Website: https://www.globalmarketestimates.com/

Check our Latest Blogs: https://www.globalmarketestimates.com/blog-posts.php